Where can I buy canakinumab?

The European Union approves Novartis' fully human monoclonal antibody canakinumab for the treatment of adults or children aged ≥4 years with cryopyrin-associated periodic syndrome (CAPS). Due to high medical need, this product received special accelerated approval in the EU after priority review approval in the United States and Switzerland. The approval was based on a clinical trial program involving approximately 100 patients.

Data from a pivotal clinical study demonstrate that canakinumab produces rapid, complete and sustained responses in the majority of patients. No patient receiving canakinumab experienced a flare, compared with 13 of 16 patients in the placebo group (0% vs 81%). In addition to its orphan drug status for CAPS, canakinumab is also classified as an orphan drug for the treatment of systemic juvenile idiopathic arthritis in the United States, the European Union and Switzerland, and has been granted fast track in the United States for this indication (Novartis News).

Where can I buy canakinumab? At present, canakinumab is not on the market, so there is no channel to buy genuine canakinumab in China. If patients want to purchase the drug, they can only go abroad. This process is long and expensive, and is not suitable for long-term medication. Therefore, patients can trust domestic and overseas medical service organizations to help you purchase canakinumab. Not only is the price more affordable than the original drug, but it is also equally effective in terms of efficacy. Medical Companion Travel's method of purchasing medicines is very safe. The medicines are guaranteed to be authentic and delivered directly to your home, saving you worry and effort. You are welcome to contact Medical Companion Travel at any time.

Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.